Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease
- PMID: 31750909
- DOI: 10.1093/ibd/izz286
Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease
Keywords: Crohn's disease; adalimumab; antitumor necrosis factor; infliximab; loss of response.
Comment in
-
Response to the Letter to the Editor: "Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease".Inflamm Bowel Dis. 2020 Jan 6;26(2):e6. doi: 10.1093/ibd/izz287. Inflamm Bowel Dis. 2020. PMID: 31750908 No abstract available.
Comment on
-
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.Inflamm Bowel Dis. 2020 Mar 4;26(4):606-616. doi: 10.1093/ibd/izz192. Inflamm Bowel Dis. 2020. PMID: 31504569
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
